| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/02/2005 | EP1509506A1 Pyridazine derivatives |
| 03/02/2005 | EP1509499A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases |
| 03/02/2005 | EP1509498A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same |
| 03/02/2005 | EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 03/02/2005 | EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/02/2005 | EP1509241A1 Novel uses of cephaibols |
| 03/02/2005 | EP1509237A2 Methods of treating angiogenesis, tumor growth, and metastasis |
| 03/02/2005 | EP1509233A1 Liquid formulation of decitabine and use of the same |
| 03/02/2005 | EP1509223A1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin |
| 03/02/2005 | EP1509216A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
| 03/02/2005 | EP1509213A2 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 03/02/2005 | EP1509199A1 Dry powder inhalant composition |
| 03/02/2005 | EP1509188A2 Compounds active at the glucocorticoid receptor ii |
| 03/02/2005 | EP1416966A4 Methods for treating joint inflammation, pain, and loss of mobility |
| 03/02/2005 | EP1412353B1 Imidazopyridinones as p38 map kinase inhibitors |
| 03/02/2005 | EP1296650B1 Methods and compositions for treating pain of the mucous membrane |
| 03/02/2005 | EP1244649B1 Cyclic amp-specific phosphodiesterase inhibitors |
| 03/02/2005 | EP1129084B1 Thiazole derivatives as ppar gamma ligands |
| 03/02/2005 | EP1042279B1 Substituted beta-alanines |
| 03/02/2005 | EP1014976B1 Novel substituted imidazole compounds |
| 03/02/2005 | EP0910397B1 Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis |
| 03/02/2005 | EP0844873B1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 03/02/2005 | EP0824530B1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 03/02/2005 | EP0799311B1 Human chemokine beta-9 |
| 03/02/2005 | CN1589279A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/02/2005 | CN1589273A The use of anti-histaminics for acute reduction of elevated intracranial pressure |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/02/2005 | CN1589270A Indole-2-formamide compounds as factor Xa inhibitors |
| 03/02/2005 | CN1589269A Heteroindanes: a new class of potent cannabimimetic ligands |
| 03/02/2005 | CN1589261A Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/02/2005 | CN1589260A Heterocyclic compounds and methods of use thereof |
| 03/02/2005 | CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds |
| 03/02/2005 | CN1589166A Stent coated with a sustained-release drug delivery system and method for use thereof |
| 03/02/2005 | CN1589145A αv整联蛋白受体拮抗剂 αv integrin receptor antagonists |
| 03/02/2005 | CN1589136A Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 03/02/2005 | CN1589134A Compositions and kits comprising a defined boron compound, methods of their preparation, and use and administration thereof |
| 03/02/2005 | CN1586604A Zedoary injection preparation and its preparing method |
| 03/02/2005 | CN1586600A Tibet medicine lamivphlomis root injection preparation and its preparing method |
| 03/02/2005 | CN1586587A Qingkailing oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586544A Medicinal wine and its producing method |
| 03/02/2005 | CN1586543A Children health pectoral mixture for treating child wind and heat caused by exopathogen and its preparing method |
| 03/02/2005 | CN1586532A Liushen oral disintegration tablet and its preparing method |
| 03/02/2005 | CN1586504A Paste for promoting blood circulation to stop pain |
| 03/02/2005 | CN1586473A Daphnetic soft capsule and its preparing method |
| 03/02/2005 | CN1586466A Compound dispersion tablet of acetaminophen and benadryl and its preparing method |
| 03/02/2005 | CN1191266C Compositions for treating inflammatory response |
| 03/02/2005 | CN1191254C Fused pyrrole compounds, pharmaceutical composition containing the same, and the use thereof |
| 03/02/2005 | CN1191243C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 03/02/2005 | CN1191240C Nitrogen monoxide synthase inhibitor, its preparation method and application |
| 03/02/2005 | CN1191239C Pyrazole derivatives for the treatment of viral diseases |
| 03/02/2005 | CN1191236C Substituted 6,6-Hetero-dicycloderivative |
| 03/02/2005 | CN1191233C N-substituted nitrogen heterocyclic compound |
| 03/02/2005 | CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 03/02/2005 | CA2479613A1 Novel adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them |
| 03/01/2005 | US6861532 Synthesis of 2-alkylcysteine |
| 03/01/2005 | US6861504 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor |
| 03/01/2005 | US6861429 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors |
| 03/01/2005 | US6861425 Benzimidazole compounds as ORL1-receptor agonists |
| 03/01/2005 | US6861421 Nociceptin analogs |
| 03/01/2005 | US6861418 Modulating protein kinase signal transduction; anticancer agents |
| 03/01/2005 | US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis |
| 03/01/2005 | US6861406 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor |
| 03/01/2005 | US6861069 Compression; concurrent spray drying, granulation |
| 03/01/2005 | US6861055 Human GDP-mannose 4,6-dehydratase |
| 02/24/2005 | WO2005016924A1 7-azaindole derivatives as cox2 inhibitors |
| 02/24/2005 | WO2005016918A2 Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 02/24/2005 | WO2005016915A1 Piperidine/cyclohexane carboxamide derivatives for use as vanilloid receptor modulators |
| 02/24/2005 | WO2005016894A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/24/2005 | WO2005016514A2 Combinatorial synthesis on support |
| 02/24/2005 | WO2005016374A1 Regulation of urokinase receptor expression by phosphoglycerate kinase |
| 02/24/2005 | WO2005016372A1 Compositions comprising polymetal-binding proteins and plant extracts for reducing free radicals |
| 02/24/2005 | WO2005016351A1 Novel use of cannabinoid receptor agonist |
| 02/24/2005 | WO2005016350A1 Ammonium salts of ornithine derivatives for treating inflammatory diseases |
| 02/24/2005 | WO2005016349A1 Methods of inhibiting leukocyte accumulation |
| 02/24/2005 | WO2005016348A1 Method of inhibiting immune responses stimulated by an endogenous factor |
| 02/24/2005 | WO2005016331A1 Therapeutic agent for neuropathic pain containing n-(benzoyl)amino acid derivative as active ingredient |
| 02/24/2005 | WO2004024088A3 Design of chemokine analogs for the treatment of human diseases |
| 02/24/2005 | WO2004009064A8 Use of neurotoxic substances for the production of a means for the treatment of joint pain and method for application of said means |
| 02/24/2005 | US20050043536 Sulfonamides |
| 02/24/2005 | US20050043534 Modulators of ceramidase and methods of used based thereon |
| 02/24/2005 | US20050043516 TACI antibodies and uses thereof |
| 02/24/2005 | US20050043410 Using an epinephrine type compound; controlling neovascularization |
| 02/24/2005 | US20050043398 such as 2-ethoxycarbonyl-7-hydroxychromone, for the care, preservation or improvement of the general state of the skin or hair |
| 02/24/2005 | US20050043394 For prophylaxis and therapy of diabetes mellitus, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases, neuropathic diseases, neuropathic pain and polyneuropathy; free fatty acids and/or fatty acid esters and uridine, deoxyuridine, uridine monophosphate, deoxyuridine monophosphate |
| 02/24/2005 | US20050043393 Antilipemic agents |
| 02/24/2005 | US20050043386 2-amino-2-(ethyl or methyl)-4-{5-substituted pyrrol-2-yl}butan-1-ols, phosphates and phosphonates; antiarthritic agents; psoriasis; immunosuppressants |
| 02/24/2005 | US20050043379 Leukotriene hydrolase inhibitors; antiinflammatory agents; antihistamines; chronic onstructive pulmonary disorders; atherosclerosis; multiple sclerosis; inflammatory bowel disorders; antiarthritic agents ;psoriasis |
| 02/24/2005 | US20050043378 LTA4H modulators |
| 02/24/2005 | US20050043350 Administering heterocyclic ether such as 5-chloro-7-hydroxy-3-(4-hydroxyphenylz)-4-oxo-1-benzopyran for prophylaxis of Alzheimer's disease, osteoporosis, cardiovascular disorders, psychological disorders, antiarthritic agents,anxiolytic agents |
| 02/24/2005 | US20050043340 Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 02/24/2005 | US20050043335 Heterocyclic derivatives of glycinamide and their medical use |
| 02/24/2005 | US20050043332 Such as 4 (cis-3-hydroxycyclopentyl)amino-5,6-dimethyl-2-phenyl-7H-pyrrolo[2,3d] pyrimidine for treatment of adenosine receptor stimulated diseases, cardiovascular disorders, and nervous system disorders |
| 02/24/2005 | US20050043330 Antiinflammation agents |
| 02/24/2005 | US20050043328 Such as 6-(2-hydroxy-3-chloroxybenzylamino)purine, 6-(2-hydroxy-4-chlorobenzylamino)purine; agriculture; cloning; immunostimulation |
| 02/24/2005 | US20050043326 Compounds |
| 02/24/2005 | US20050043305 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 02/24/2005 | US20050043304 Lower alkyl molecular weight amine as enzyme inhibitors for use in the treatment of tryptase enzyme inhibitors inhibitorsfor respiratory system disorders, antiinflammatory agents, inflammatory bowel disease, hyperprolific skin disorders, vascular edema and rheumatoid arthritis |
| 02/24/2005 | US20050043302 New indole derivatives as factor Xa inhibitors |
| 02/24/2005 | US20050043284 containing an anti-inflammatory and anti-allergic compound of the androstane series |
| 02/24/2005 | US20050043281 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system |